These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 6390852

  • 1. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL, Nelson PW, Colvin RB, Cosimi AB.
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract] [Full Text] [Related]

  • 2. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
    Thomas F, Mendez-Picon G, Thomas J, Lee HM.
    Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
    [No Abstract] [Full Text] [Related]

  • 3. Use of antithymocyte globulin for reversal of acute allograft rejection.
    Shield CF, Cosimi AB, Tolkoff-Rubin N, Rubin RH, Herrin J, Russell PS.
    Transplantation; 1979 Dec; 28(6):461-4. PubMed ID: 390784
    [No Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies for kidney allograft rejection.
    Med Lett Drugs Ther; 1986 Oct 10; 28(724):97-8. PubMed ID: 3531791
    [No Abstract] [Full Text] [Related]

  • 5. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP, Brown EA, Woodrow DF, Phillips ME, Gower PE, Mee AD.
    Transplantation; 1991 Oct 10; 52(4):746-9. PubMed ID: 1926361
    [No Abstract] [Full Text] [Related]

  • 6. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F, Cunningham P, Thomas J, Gross U, Gaskins D, Sash C, Parker K.
    Transplant Proc; 1987 Feb 10; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract] [Full Text] [Related]

  • 7. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL.
    Transplant Proc; 1984 Aug 10; 16(4):979-82. PubMed ID: 6380062
    [No Abstract] [Full Text] [Related]

  • 8. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG, Blackstone E, Whelchel JD, Pass RF, Chambers L, Phillips SJ, Thiry C.
    Transplant Proc; 1979 Mar 10; 11(1):27-30. PubMed ID: 377644
    [No Abstract] [Full Text] [Related]

  • 9. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
    Birkeland SA, Svendsen V, Rohr N, Hansen BL, Elbirk A, Foged N, Køhler F.
    Transplant Proc; 1988 Jun 10; 20(3):451-4. PubMed ID: 3289183
    [No Abstract] [Full Text] [Related]

  • 10. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL, Butt KH, Rao TK, Zielinski CM, Rafi M, Schultz JR.
    Transplant Proc; 1977 Mar 10; 9(1):1023-5. PubMed ID: 325728
    [No Abstract] [Full Text] [Related]

  • 11. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
    Toledo-Pereyra LH, Bergren C, Mittal VK, Whitten JI, Baskin S, McNichol L.
    Transplantation; 1985 Oct 10; 40(4):448-50. PubMed ID: 3901446
    [No Abstract] [Full Text] [Related]

  • 12. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U, Frei D, Keusch G, Burger HR, Largiader F, Binswanger U.
    Transplant Proc; 1988 Oct 10; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract] [Full Text] [Related]

  • 13. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J, Dickerman R, Vergne-Marini P, Williams J, Jensik S, Kenyon N, Anderson J.
    Transplant Proc; 1993 Feb 10; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ, Van Lier HJ, Reekers P, Koene RA.
    Neth J Med; 1985 Feb 10; 28(6):239-42. PubMed ID: 3892324
    [No Abstract] [Full Text] [Related]

  • 15. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG, May J, Rogers JH, Storey BG, Katran DC, Duggin GG, Johnson JR, Stewart JH.
    Transplant Proc; 1973 Mar 10; 5(1):561-5. PubMed ID: 4121179
    [No Abstract] [Full Text] [Related]

  • 16. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Oct 10; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract] [Full Text] [Related]

  • 17. Multicenter comparative study of an anti-LFA-1 adhesion molecule monoclonal antibody and antithymocyte globulin in prophylaxis of acute rejection in kidney transplantation.
    Hourmant M, Bedrossian J, Durand D, Kessler M, Le Branchu Y, Caudrelier P, Simi B, Soulillou JP.
    Transplant Proc; 1995 Feb 10; 27(1):864. PubMed ID: 7879209
    [No Abstract] [Full Text] [Related]

  • 18. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF, Stern S, Beizer R, Sklar L, Bannett A.
    Transplant Proc; 1979 Jun 10; 11(2):1431-2. PubMed ID: 382532
    [No Abstract] [Full Text] [Related]

  • 19. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
    Alamartine E, Bellakoul R, Berthoux F.
    Transplant Proc; 1994 Feb 10; 26(1):273-4. PubMed ID: 8108975
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.